Periodontal treatment to improve glycaemic control in diabetic patients: study protocol of the randomized, controlled DIAPERIO trial
Authors:
- Jean-Noel VergnesJean-Noel Vergnes
- Elise ArrivéEAElise Arrivé
- Pierre GourdyPGPierre Gourdy
- Hélène HanaireHHHélène Hanaire
- Vincent RigalleauVRVincent Rigalleau
- Henri GinHGHenri Gin
- Cyril SédaratCSCyril Sédarat
- Georges DorignacGDGeorges Dorignac
- Christophe BouCBChristophe Bou
- Michel SixouMSMichel Sixou
- Cathy NabetCNCathy Nabet
Open Access
- 2 August 2009
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 10 (1) , 65
Abstract
Periodontitis is a common, chronic inflammatory disease caused by gram-negative bacteria leading to destruction of tissues supporting the teeth. Epidemiological studies have consistently shown increased frequency, extent and severity of periodontitis among diabetic adults. More recently, some controlled clinical trials have also suggested that periodontal treatment could improve glycaemic control in diabetic patients. However current evidence does not provide sufficient information on which to confidently base any clinical recommendations. The main objective of this clinical trial is to assess whether periodontal treatment could lead to a decrease in glycated haemoglobin levels in metabolically unbalanced diabetic patients suffering from chronic periodontitis.The DIAPERIO trial is an open-label, 13-week follow-up, randomized, controlled trial. The total target sample size is planned at 150 participants, with a balanced (1:1) treatment allocation (immediate treatment vs delayed treatment). Periodontal treatment will include full mouth non-surgical scaling and root planing, systemic antibiotherapy, local antiseptics (chlorhexidine 0.12%) and oral health instructions. The primary outcome will be the difference in change of HbA1c between the two groups after the 13-weeks' follow-up. Secondary outcomes will be the difference in change of fructosamine levels and quality of life between the two groups.The DIAPERIO trial will provide insight into the question of whether periodontal treatment could lead to an improvement in glycaemic control in metabolically unbalanced diabetic patients suffering from periodontitis. The results of this trial will help to provide evidence-based recommendations for clinicians and a draft framework for designing national health policies.Current Controlled Trials ISRCTN15334496.Keywords
This publication has 16 references indexed in Scilit:
- Dose–response relationship between periodontal inflamed surface area and HbA1c in type 2 DiabeticsJournal of Clinical Periodontology, 2009
- Effect of periodontal therapy on general health – is there a missing component in the design of these clinical trials?Journal of Clinical Periodontology, 2008
- Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studiesDiabetes & Metabolism, 2008
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Periodontal inflamed surface area: quantifying inflammatory burdenJournal of Clinical Periodontology, 2008
- Epidemiology of periodontal status in dentate adults in France, 2002–2003Journal of Periodontal Research, 2007
- Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes StudyJournal of Clinical Periodontology, 2006
- Diabetes Mellitus and Periodontal DiseasesJournal of Periodontology, 2006
- The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjectsOral Diseases, 2005
- The effect of improved periodontal health on metabolic control in type 2 diabetes mellitusJournal of Clinical Periodontology, 2005